UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017295
Receipt number R000020065
Scientific Title An exploratory trial of betaine supplementation in patients with schizophrenia
Date of disclosure of the study information 2015/06/01
Last modified on 2020/10/29 12:32:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An exploratory trial of betaine supplementation in patients with schizophrenia

Acronym

An exploratory trial of betaine supplementation in patients with schizophrenia

Scientific Title

An exploratory trial of betaine supplementation in patients with schizophrenia

Scientific Title:Acronym

An exploratory trial of betaine supplementation in patients with schizophrenia

Region

Japan


Condition

Condition

Schizophrenia

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To investigate safety and efficacy of betaine supplementation on clinical symptoms and functioning in patients with schizophrenia

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Phase II


Assessment

Primary outcomes

Global Assessment of Functioning (GAF)
Adverse events

Key secondary outcomes

Positive and Negative Syndrome Scale (PANSS)
Plasma total homocysteine
Plasma homocystine
Plasma methionine
Serum vitamin B6
Serum vitamin B12
Serum folate
DNA


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Administration of betaine (3g) twice per day (6g/day) for 8 weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

64 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Diagnosed as schizophrenia based on DSM-IV-TR
2) Written informed consent after a detailed explanation of this study

Key exclusion criteria

1) History of allergy to drugs
2) History of substance use disorder
3) High risk of suicide or other-injuring behavior
4) No agreement with contraception during participation of this study
5) Comorbidity or history of serious physical diseases
6) Organic brain disorder requiring treatment
7) Infection with HIV or hepatitis virus
8) Serious abnormality of vital sign, laboratory data, or electrocardiogram
9) Involuntarily hospital admission
10) Restriction of behavior
11) No disease notification
12) Electroconvulsive therapy or transcranial magnetic stimulation within 3 months before participation of this study
13) History of betaine use
14) Use of investigational drug within 3 months before participation of this study
15) More than 500 micromol/L of plasma methionine level
16) Doctor's decision

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Kiyoto
Middle name
Last name Kasai

Organization

The University of Tokyo Hospital

Division name

Department of Neuropsychiatry

Zip code

113-8655

Address

7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan

TEL

03-3815-5411

Email

kasaik-tky@umin.ac.jp


Public contact

Name of contact person

1st name Kenji
Middle name
Last name Kirihara

Organization

The University of Tokyo Hospital

Division name

Department of Neuropsychiatry

Zip code

113-8655

Address

7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan

TEL

03-3815-5411

Homepage URL


Email

kirihara-tky@umin.ac.jp


Sponsor or person

Institute

Department of Neuropsychiatry, The University of Tokyo Hospital

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The University of Tokyo, Clinical Research Review Board

Address

7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan

Tel

03-5841-0818

Email

ethics@m.u-tokyo.ac.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

jRCTs031180371

Org. issuing International ID_1

Japan Registry of Clinical Trials

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京大学医学部附属病院(東京都)


Other administrative information

Date of disclosure of the study information

2015 Year 06 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

15

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2015 Year 02 Month 19 Day

Date of IRB

2015 Year 01 Month 29 Day

Anticipated trial start date

2016 Year 12 Month 06 Day

Last follow-up date

2020 Year 06 Month 23 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 04 Month 27 Day

Last modified on

2020 Year 10 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020065


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name